VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $719,000 | -40.4% | 28,214 | -39.9% | 0.05% | -21.7% |
| Q1 2022 | $1,207,000 | -38.5% | 46,914 | 0.0% | 0.07% | -31.0% |
| Q4 2021 | $1,964,000 | -4.2% | 46,914 | -0.4% | 0.10% | -10.7% |
| Q3 2021 | $2,050,000 | -9.2% | 47,095 | -1.3% | 0.11% | -9.7% |
| Q2 2021 | $2,257,000 | -7.8% | 47,739 | 0.0% | 0.12% | -16.2% |
| Q1 2021 | $2,448,000 | +86.7% | 47,739 | -2.5% | 0.15% | +92.2% |
| Q4 2020 | $1,311,000 | -22.0% | 48,973 | 0.0% | 0.08% | -32.5% |
| Q3 2020 | $1,681,000 | – | 48,973 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |